Lower insulin secretion is associated with hippocampal and parahippocampal gyrus atrophy in elderly patients with type 2 diabetes mellitus
Yuko Adachi, Kazuki Ota, Isao Minami and 2 more
Journal of Diabetes Investigation · 2021
doi:10.1111/jdi.13554 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Aims/Introduction We aimed to examine the association between diabetes‐related parameters and hippocampal and parahippocampal gyrus atrophy (HPGA) in patients with type 2 diabetes mellitus to elucidate the risk factors for HPGA, which is often accompanied by Alzheimer’s disease. Materials and methods A total of 137 patients aged ≥50 years with type 2 diabetes mellitus (mean age 67.8 ± 9.8 years) underwent brain magnetic resonance imaging scans and comprehensive health examinations. We measured the volume of interest – a portion of the inner temporal lobe that includes the hippocampus, amygdala and entorhinal cortex (frontal part of the parahippocampal gyrus) – using the voxel‐based specific regional analysis system for Alzheimer’s disease in each patient. The diabetes‐related parameters included glycated hemoglobin, fasting plasma glucose, C‐peptide (CPR) index (serum CPR / fasting plasma glucose × 100) and duration of diabetes. Results The mean glycated hemoglobin was 9.3 ± 2.2%, the median CPR index was 1.29 (interquartile range 0.85–1.74) and the median duration of diabetes was 10 years (interquartile range 3–20 years). The severity score of volume of interest atrophy was >1.0 in 36 patients. Using multivariate logistic regression analysis, we found that age (odds ratio 1.09, 95% confidence interval 1.02–1.15) and CPR index (odds ratio 0.451, 95% confidence interval 0.216–0.940) were significantly associated with HPGA. Conclusions Lower insulin secretion was significantly associated with HPGA in patients with type 2 diabetes mellitus. The results of this study support the hypothesis that insulin‐signaling abnormalities are involved in the pathophysiology of Alzheimer’s disease.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.